2. HOME
  3. Annual Meeting
  4. Archive
  5. 年会2023
  6. Program Outline: the 14th Annual Meeting (as of Feb. 9, 2023).

学術年会

Program Outline: the 14th Annual Meeting (as of Feb. 9, 2023).

Here is the program outline (as of February 9, 2023) of the 14th annual meeting.

10:00 〜 Opening Remarks by President of the 14th annual meeting,
Notices from the 14th JSPS annual meeting
10:10 〜 11:00 Educational Lecture
Roles of nonclinical safety data in clinical application
Yuji Kumagai (Kitasato Clinical Research Center, Kitasato University School of Medicine)
Session Chair: Atsushi Fujiwara (Ina Research Inc.), Hiroyuki Tashibu (Ina Research Inc.)
11:20 - 11:40 Exhibitor's Flash Talk
Moderator: Erina Katayama (Sophion Bioscience Inc.), Takeshi Ishii (Drug Safety Testing Center Co., Ltd.)
11:40 - 12:10 Poster Presenters' Flash Talk
Moderator: Takafumi Shirakawa (Astellas Pharma Inc.),  Hiroyuki Ando (Ono Pharmaceutical Co.,Ltd.),  Toshiki Kagawa (Mitsubishi Tanabe Pharma Corporation)
12:30 - 13:20 Lunchoen Seninar sponsored by Eurofins Discovery
  1. Central Nervous System Safety Screening: Practical Considerations for New Drug Development and Regulatory Science
    Chun-Yao Lee（Eurofins Panlabs Discovery Services Taiwan, Ltd.）

  2. Comprehensive Identification of Potential Cardiac Safety Liabilities Using a Totality of Evidence Approach
    Muthukrishnan Renganathan (Eurofins Panlabs Inc.）

Moderator: Makoto Imatachi (Eurofins Discovery)
14:00 - 15:10 Symposium 1 (New Technologies)
  1. Current status of Microphysiological systems research in Toxicological science
    Hitoshi Naraoka, Ph.D., MBA (Non-clinical Biomedical Science, Applied Research & Operations, Astellas Pharma Inc.）

  2. Lung toxicology utilizing respiratory organoids
    Yuki Yamamoto, M.D., Ph.D (HiLung Inc.)
Session Chair: Tomoharu Osada (LSI Medience Corporation), Keiichi Asakura (Nippon Shinyaku Co., Ltd.)
15:30 - 16:50 Workshop (Envisioning the implementation of ICH E14/S7B Q&As）
  1. Implementation of Best Practice in vitro hERG Assay under ICH E14/S7B Q&As: DSTC's efforts
    Hiroshi Matsukawa（Drug Safety Testing Center Co., Ltd.）

  2. Considerations for in vivo QT studies in terms of E14/S7B Q&As: the practical case of J-ICET ECG working group
    Ryuichi Komatsu (Chugai Pharmaceutical Co., LTD.)

  3. Panel Discussion
    Panelists:
    Hiroshi Matsukawa (Drug Safety Testing Center Co., Ltd)
    Ryuichi Komatsu (Chugai Pharmaceutical Co., LTD.)
    Satoshi Tsunoda (Pharmaceuticals and Medical Devices Agency)
    Takashi Yoshinaga (Eisai Co., Ltd.)
    Katsuyoshi Chiba (Daiichi Sankyo, Inc.)
Session Chair: Tomohiko Taniguchi (Eisai Co., Ltd.), Taeko Kubo (Sumitomo Pharma Co., Ltd.)
- 17:00 Poster viewing area closed.

メインメニュー